Longevity & AgingPress Release

Smoking Duration Alone May Simplify Lung Cancer Screening Better Than Current Guidelines

New research finds years smoked — not pack-years — may better identify who benefits most from low-dose CT lung cancer screening.

Tuesday, June 30, 2026 1 view
Published in MedPage Today
Article visualization: Smoking Duration Alone May Simplify Lung Cancer Screening Better Than Current Guidelines

Summary

Lung cancer screening is critically underused, with fewer than 20% of eligible people getting scanned. A new observational study published in JAMA Internal Medicine suggests that simply counting how many years a person has smoked may be a better screening criterion than the current USPSTF guidelines, which rely on pack-years and time since quitting. Researchers found that thresholds of 20, 30, or 40 years of smoking identified more high-risk individuals than current criteria. However, lower thresholds like 20 years vastly expanded the eligible pool, including many unlikely to benefit. A 40-year threshold struck the best balance between catching high-risk individuals and excluding low-risk ones. Experts note that no single rule perfectly captures lung cancer risk diversity among ever-smokers.

Detailed Summary

Lung cancer remains one of the deadliest cancers, and early detection via low-dose CT screening can save lives — yet fewer than 20% of eligible individuals currently get screened. A major reason is complexity: current U.S. Preventive Services Task Force (USPSTF) guidelines require calculating pack-years and accounting for years since quitting, criteria that are difficult to apply consistently in clinical settings.

A new nationally representative cohort study led by Dr. Lauren Kearney of Boston University School of Medicine, published in JAMA Internal Medicine, tested whether simply using total years of smoking could serve as a more practical screening criterion. The researchers evaluated thresholds of 20, 30, and 40 years of smoking and compared how well each identified individuals most likely to benefit from screening versus USPSTF criteria.

All three years-smoked thresholds outperformed USPSTF criteria in capturing the highest-benefit individuals. A 20-year threshold was the most inclusive, catching nearly all high-benefit individuals, but it also dramatically expanded the screened population and included many low-benefit candidates — a resource and efficiency concern. A 40-year threshold offered the strongest balance, better identifying high-risk individuals while also more effectively excluding those least likely to benefit.

An accompanying editorial from MD Anderson Cancer Center cautioned that no single simplified rule can fully capture the heterogeneity of lung cancer risk among ever-smokers. The editorialists suggested combining simplified eligibility thresholds with individualized risk prediction models as the most promising path forward.

For health-conscious adults with a smoking history, this research underscores the importance of discussing screening eligibility with a physician — even if current guidelines suggest you may not qualify. Simpler, more intuitive criteria could eventually improve screening uptake and save more lives, but policy decisions will need to weigh efficiency against the imperative not to miss high-risk individuals.

Key Findings

  • Years of smoking alone outperformed USPSTF pack-year criteria in identifying high-risk individuals for lung cancer screening.
  • A 40-year smoking threshold best balanced catching high-risk individuals while excluding low-benefit candidates.
  • A 20-year threshold captured nearly all high-benefit individuals but greatly expanded the screening-eligible population.
  • Fewer than 20% of currently eligible individuals undergo recommended low-dose CT lung cancer screening.
  • Experts recommend combining simplified thresholds with personalized risk models for optimal screening precision.

Methodology

This is a news report summarizing a peer-reviewed observational cohort study published in JAMA Internal Medicine, a high-credibility journal. The study used a nationally representative cohort, lending generalizability, though observational design limits causal conclusions. An accompanying editorial from MD Anderson Cancer Center provides additional expert context.

Study Limitations

The full study methods and cohort details are not available from this news summary alone; readers should consult the primary JAMA Internal Medicine publication. Observational studies cannot establish causation, and optimal years-smoked thresholds may vary by population demographics. No single eligibility rule fully captures individual lung cancer risk variation.

Enjoyed this summary?

Get the latest longevity research delivered to your inbox every week.

Enter your email to subscribe: